Abstract
Baricitinib (Olumiant(TM)) is an orally-administered, small-molecule, janus-associated kinase (JAK) inhibitor developed by Eli Lilly and Incyte Corpor......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
